Login / Signup

Evans syndrome during pembrolizumab therapy for upper urinary tract cancer.

Shota KakitaTomohiro MatsuoMasaharu OhkiAyaka TsuchiyamaTakuji YasudaHiromi NakanishiKensuke MitsunariKojiro OhbaRyoichi Imamura
Published in: IJU case reports (2023)
This report highlights the potential risk of Evans syndrome associated with immune checkpoint inhibitor treatment. Clinicians should be aware of this possibility and consider early intervention with corticosteroids.
Keyphrases
  • urinary tract
  • randomized controlled trial
  • case report
  • papillary thyroid
  • palliative care
  • squamous cell carcinoma
  • squamous cell
  • risk assessment
  • human health
  • lymph node metastasis
  • climate change
  • replacement therapy